The effects of CenteringPregnancy group prenatal care on postpartum visit attendance and contraception use.


Journal

Contraception
ISSN: 1879-0518
Titre abrégé: Contraception
Pays: United States
ID NLM: 0234361

Informations de publication

Date de publication:
07 2020
Historique:
received: 04 06 2019
revised: 19 02 2020
accepted: 19 02 2020
pubmed: 3 3 2020
medline: 16 10 2021
entrez: 2 3 2020
Statut: ppublish

Résumé

We examined whether Medicaid-enrolled women in CenteringPregnancy group prenatal care had higher rates of (1) postpartum visit attendance and (2) postpartum uptake of contraceptives, compared to women in individual prenatal care. We linked birth certificates and Medicaid claims for women receiving group prenatal care in 18 healthcare practices and applied preferential-within cluster propensity score methods to identify a comparison group, accounting for the nested data structure by practice. We examined five standardized, claims-based outcomes: postpartum visit attendance; contraception within 3 days; and any contraception, long-acting reversible contraception (LARC), and permanent contraception within eight weeks. We assessed outcomes using logistic regression for two treatment levels: (1) any group attendance compared to no group attendance and (2) attendance at five or more group sessions to at least five prenatal care visits, including crossovers attending fewer than five group sessions (minimum threshold analysis). Women attending at least five group sessions had higher rates of postpartum visit attendance (71.5% vs. 67.5%, p < .05). Women with any group attendance (N = 2834) were more likely than women with individual care only (N = 13,088) to receive contraception within 3 days (19.8% vs. 16.9%, p < .001) and to receive a LARC within eight weeks' postpartum (18.0% vs. 15.2%, p < .001). At both treatment levels, group participants were less likely to elect permanent contraception (5.9% vs. 7.8%, p < 0.001). Women meeting the five-visit group threshold were not more likely to initiate contraception or LARCs within 8 weeks' postpartum. Participation in at least five group compared to five individual prenatal care visits is associated with greater rates of postpartum visit attendance. Additional engagement and education in group prenatal care may influence postpartum visit attendance. Planning for postpartum care and contraception during prenatal care is an important strategy for connecting women to postpartum healthcare. Regardless of prenatal care model, women have low uptake of contraception in the postpartum period. Increased use of group prenatal care with its scheduled family planning discussion may help to increase postpartum contraceptive uptake. This benefit is dependent on availability of postpartum contraception options.

Identifiants

pubmed: 32114005
pii: S0010-7824(20)30063-9
doi: 10.1016/j.contraception.2020.02.010
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

46-51

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Emily Heberlein (E)

Georgia Health Policy Center, Georgia State University, 55 Park Place NE, Atlanta, GA 30303, United States. Electronic address: eheberlein@gsu.edu.

Jessica Smith (J)

Georgia Health Policy Center, Georgia State University, 55 Park Place NE, Atlanta, GA 30303, United States. Electronic address: jsmith492@gsu.edu.

Carla Willis (C)

Georgia Health Policy Center, Georgia State University, 55 Park Place NE, Atlanta, GA 30303, United States. Electronic address: Carla.willis@dch.ga.gov.

Wendasha Hall (W)

Georgia Health Policy Center, Georgia State University, 55 Park Place NE, Atlanta, GA 30303, United States. Electronic address: whall14@gsu.edu.

Sarah Covington-Kolb (S)

Prisma Health, 890 W. Faris Road, Suite 420, Greenville, SC 29605, United States. Electronic address: sarah.covkolb@gmail.com.

Amy Crockett (A)

Prisma Health, 890 W. Faris Road, Suite 420, Greenville, SC 29605, United States. Electronic address: amy.crockett@prismahealth.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH